Old Articles: <Older 8271-8280 Newer> |
|
CIO February 24, 2012 Shane O'Neill |
Android On Call: Hospital Builds Custom Mobile App for Patient Data Palomar Pomerado Health in San Diego built its own Android app for accessing real-time patient information, with Cisco Cius tablets providing the added bonus of voice and video. And an iOS version is coming up, stat. |
Chemistry World February 14, 2012 Rebecca Trager |
FDA proposes biosimilars approval pathway The US Food and Drug Administration has released its long awaited guidance to assist in the development and approval of so-called 'biosimilars' - biological drugs that are very similar to licensed ones. |
Pharmaceutical Executive February 1, 2012 Ben Comer |
Prizing the Eye : Brent Saunders, CEO Bausch + Lomb Bausch + Lomb CEO Brent Saunders refocuses on the customer. |
Pharmaceutical Executive February 1, 2012 Wilcox et al. |
Sales Force Survey: Still Too Much Business as Usual? In the global battle for market share, the ability to adapt and mobilize your human assets around a responsive commercial model is a key variable of success. |
Pharmaceutical Executive February 1, 2012 Ben Comer |
Best to Market Pharm Exec's Brand of the Year: Abbott's Humira |
Pharmaceutical Executive February 1, 2012 William Looney |
Brand Success: It's Not Serendipity A new generation of products for inflammatory disease is coming forward, promising better promise and possibly a cure. |
Pharmaceutical Executive February 1, 2012 Schaeffer & Dahlberg |
Money for Nothing, Patents for Free? State tech transfer laws giving universities automatic ownership of employees' inventions represent a threat to pharma partnerships. |
Pharmaceutical Executive February 1, 2012 Sarah Krug |
Introducing the 'Chief Patient Officer' Now is the time for pharma companies to appoint a Chief Patient Officer, a new position designed to build an accord around patient trust. |
Pharmaceutical Executive February 1, 2012 Topin & Mansfield |
Finding that Perfect Pitch A good creative brief takes raw information and makes it come alive. |
Pharmaceutical Executive February 1, 2012 Jill Wechsler |
Costs and Benefits of Health Reform Will expanded markets and accountable care organizations offset higher rebates, added fees, and closer scrutiny of marketing and prices? |
<Older 8271-8280 Newer> Return to current articles. |